Cardinal Health, of Dublin, Ohio, and U.K.-based GE Healthcare are working together to broaden the availability of GE Healthcare's Myoview (Tetrofosmin) cardiac imaging agent through Cardinal Health's leading network of specialized nuclear pharmacies.

As a result, Cardinal Health's customers will receive greater access to Myoview, a leading myocardial perfusion imaging technetium agent used in the diagnosis and treatment of heart disease.

"With this agreement, Myoview will over time become the flagship branded cardiac imaging agent offered through Cardinal Health's nuclear pharmacies," said John Rademacher, president, Nuclear and Specialty Pharmacy Services for Cardinal Health. "Our commitment to the nuclear pharmacy business runs deep, and partnering with GE Healthcare to provide broader access to their product portfolio illustrates the unique way Cardinal Health can bring service and value to our customers and the nuclear medicine community."

The largest employer of nuclear pharmacists in the world, Cardinal Health operates the largest radiopharmacy network in the United States with more than 150 nuclear pharmacy locations.